Invokana® Ketoacidosis Lawsuit
Were you hospitalized after being prescribed Invokana® – a medication used to treat type II diabetes?
Goldberg Finnegan drug litigation lawyers are currently reviewing the injury claims of patients who have experienced ketoacidosis or kidney failure after being prescribed this medication. Research shows that patients who take these drugs face an increased risk of severe side effects, including a serious medical condition that elevates levels of acid in the blood.
Patients experiencing life-threatening complications may be entitled to financial compensation if their injuries were caused by prescription medications that were supposed to protect them.
Invokana’s Dangerous Side Effects
The Centers for Disease Control and Prevention (CDC) estimates that more than 25 million Americans suffer from type II diabetes. Pharmaceutical companies have been rushing to produce medications for this growing and lucrative market.
Unfortunately, the newest class of diabetes medications may have side effects that are so dangerous, they outweigh the benefits. Diabetes patients have reported, and medical professionals have confirmed, that Invokana and similar drugs cause a variety of side effects, which range from mild, to severe, and can even be fatal.
The most dangerous side effects of Invokana include:
- Cardiac arrest
- Kidney failure
- Diabetic ketoacidosis
Diabetic ketoacidosis has proven to be one of the most serious and hidden conditions caused by Invokana. The condition can lead to a diabetic coma and because the symptoms are often difficult to identify, patients may not readily know that they suffer from the condition.
The condition occurs when the cells of diabetes patients do not have sufficient glucose to burn for energy. When glucose is absent, the body then turns to burning fat for energy causing patients to produce ketones.
Ketones are acidic fatty acids, which can lead to inflammation, diabetic comas and swelling in the brains of patients.
Symptoms of a diabetic ketoacidosis include:
- Frequent urination
- Nausea or abdominal pains
- Dry or flushed skin
Anyone with the listed symptoms should immediately contact a medical professional for assistance.
FDA Issues Safety Alert Regarding Invokana and Similar Drugs
In December 2015, the Food and Drug Administration’s safety review of sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs, resulted in the administration revising labels to add warnings about the risks of too much acid in the blood and/or serious urinary tract infections. During the FDA’s investigation, it found more than 70 cases of ketoacidosis in patients with type 1 or type 2 diabetes who were being treated with SGLT2 inhibitors.
In May 2015, the FDA issued an initial safety communication that the use of Invokana and other SGLT2 inhibitors could lead to too much acid in the blood of diabetes patients.
The FDA alerted the medical community to reports that more than twenty diabetes patients prescribed Invokana and similar drugs across America experienced ketoacidosis and were hospitalized for treatment.
The FDA’s safety alert warned both patients and doctors that all of the diabetes drugs in the same class as Invokana could lead to ketoacidosis and other serious side effects. These include:
- Xigduo XR
The FDA relies on the Adverse Event Reporting Systems (AERS) database to determine the wide spread nature of dangerous side effects in prescription medication.
The first reports of injury by Invokana and similar drugs occurred in March 2013, and the FDA has become concerned by the increasing number of doctors reporting that their patients have been injured by the dangerous side effects of SGLT2 inhibitors.
Diabetes Injury Lawsuits Under Investigation
In a successful diabetes injury lawsuit, diabetic patients in Maryland and Washington D.C., may be able to recover financial compensation for their injuries.
Experienced attorneys at Goldberg Finnegan have been litigating large pharmaceutical lawsuits for decades. Because these types of cases are so complex and because so much is at stake, it is vital that diabetic patients pick attorneys who have the actual resources to hold these companies accountable.
Our attorneys represent diabetes patients on contingency fee basis so that injured patients do not have to make up-front payments.
In contingency fee cases, you don’t pay anything unless you win a jury verdict or settlement.
Goldberg Finnegan dangerous drug attorneys have worked on medical injury cases and have obtained millions of dollars for injured patients and their families.
Professionals are on standby to help you schedule a free consultation of your case. Tell us what is wrong, and our law firm will provide a viable legal solution.